RecruitingNCT03616483
The Indiana Myeloma Registry
Collection of Specimens and Clinical Data to Create A Bio-repository for the Multiple Myeloma Program: The Indiana Myeloma Registry
Sponsor
Indiana University
Enrollment
2,500 participants
Start Date
Jun 18, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
This is a prospective, non-interventional, observational study. The purpose of this study is to collect data and bio-specimens that will support future research
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- Male or female patients ≥ 18 years of age at the time of informed consent
- Has been diagnosed with or is suspected to have one of the following:
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Smoldering Multiple Myeloma
- Multiple Myeloma
- Bony or Soft Tissue Plasmacytoma
- Primary Amyloidosis
Exclusion Criteria3
- \< 18 years of age
- Have not been diagnosed with one of the following:
- Monoclonal Gammopathy of Undetermined Significance (MGUS) b.Smoldering Multiple Myeloma c.Multiple Myeloma d.Bony or Soft Tissue Plasmacytoma e.Primary Amyloidosis
Interventions
OTHERThis is a non-interventional trial
This is a non-interventional trial
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03616483